Sign up to save your podcasts
Or
Share Code Clarity
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Code Clarity
By Code ClarityEducation
Code Clarity episodes
- S7 E5: One event, three complaints & an easy fix
One third-party event, three pharma company sponsors & three complaints. All about the same thing - sponsorship declarations. If you organise third party events sponsored by pharma, Rina & Jean summarise what you can do to make compliance easier. (Cases/0556/04/25;/0557/04/25 & /0558/04/25)
4 min - S7 E4: Technicality or PMCPA Precedent for MSLs
A recent ruling found a MSL presenting at a promotional meeting no breach but why? Was it a technicality or a new PMCPA position?
3 min - S7 E3: There's no such thing as a compliant venue
Rina & Jean discuss the criteria in determing if a meeting is compliant. Venue is only one!
3 min - S7 E2: "Every breath matters" - does that promote a specific medicine?
Rina & Jean discuss a recently published PMCPA ruling vs GSK about their corporate ad - placed before a finance podcast for the public. Was this actually promotion to the public or genuinely good corporate affairs work?
3 min - S7 E1: How Theramex walked away from PMCPA jurisdiction and what it means for pharma self-regulation
Theramex is the third UK pharma company to leave PMCPA jurisdiction in three years (Sandoz 2023, Evolus 2024, Theramex 2026).
Does that reflect increasing rules, companies avoiding audit, or self-regulation management of issues?
Rina & Jean discuss how we got here and what it means for the future of self-regulation.
6 min - S6 E8: Why Skills Matter in AQP and Signatory Roles
Competence is not just about job titles. Rina & Jean discuss why real skills and practical experience remain essential to understanding the INTENT behind the Code to applying JUDGEMENT in complex approval scenarios. The Code Clarity Final Signatory & AQP Collections are available now.
4 min - S6 E7: Global Voices, UK Rules: When Senior Leaders Speak to the Media
In this episode, Rina and Jean discuss what happens when senior global leaders speak about medicines in UK national media - and why even well-intentioned interviews can cross into promotion of prescription-only medicines to the public. (Full cases here: 0277 & 0518 )
The takeaway is surprisingly simple. Only 3 minutes for our ONE top tip.4 min - S6 E6: “The Best” isn’t balanced: Patient Testimony and Three AZ Video Breaches
Patient stories are powerful and that’s exactly why pharma want to use them.
In this episode, Rina and Jean analyse three AstraZeneca videos that used patient testimony describing treatment as “the best”, and why that language ultimately led to PMCPA breaches.
A must-listen for anyone approving patient-facing or patient-led materials under the ABPI Code.
(Case/0360/11/24 & /0355/11/24 & /0377/11/24)
3 min - S6 E5: Social Media, Pharma and the PMCPA: Three Changes You Really Need to Know
In this episode, Rina and Jean dissect the new PMCPA social media guidance and highlight three key changes that add clarity for pharma companies.
Essential listening for anyone signing off or posting pharma content online.
4 min - S6 E4: What’s in the Package? PMCPA’s New Deal on Package Deals
The PMCPA has published 14 page guidance on Package Deals. We cut through the fluff and tell you what you need to know & why reviewing existing arrangements now matters for compliance and transparency.
4 min
About Code Clarity
From the publisher's feed
We believe that compliance confidence should belong to the many, not just a few.
The Code Clarity Podcast is the first and only podcast relating to ABPI Code compliance - for pharma and associated agencies.